Latest news and press releases about Azenta, Inc. (AZTA): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services.
Price
| Price | $42.73 |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.16 |
| EV / EBITDA | -14.87 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -7.56% |
| Return on Invested Capital | -1.01% |
| Return on Assets | -6.55% |
| Gross Margin | 44.05% |
| Operating Margin | -3.49% |
| Net Margin | -20.02% |
Related companies: BLFS · ESTA · EVO · KMTS · NEOG · NVCR · SDGR
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of AZTA: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks